Solitary plasmacytoma.
One lesion, but 3 possible entities with differing prognosis in the differential diagnosis.
Outcomes and management. @MayoMyeloma @BloodAdvances @ASH_hematology https://t.co/f1ZE9EBv8R
Is risk-adapted therapy ready for prime time in Multiple Myeloma? Check out our recent review looking at risk definitions and MRD-guided therapy for MM
@myelomaMD @MayoMyeloma
Free article link here:
https://t.co/lP2RXp1Cb9
PICC Line Insertion: Comprehensive Review for Hematology
1️⃣ Indications for PICC Lines in Hematology
•Chemotherapy Requiring PICC:
•Vesicant drugs: Anthracyclines (e.g., Doxorubicin, Daunorubicin), Vincristine, Cisplatin.
•Irritants: Hypertonic saline, parenteral nutrition, amphotericin B.
•Continuous infusions: Cytarabine, Etoposide, Methotrexate (high-dose regimens).
•Prolonged treatment: Consolidation/maintenance phases requiring repeated cycles.
•Stem Cell Transplant: Conditioning regimens (e.g., Busulfan, Fludarabine).
•High-flow drugs: Antibiotics (e.g., Vancomycin), antifungals, or supportive care agents.
2️⃣ Complications
Early Complications:
•Insertion-related:
•Hematoma, arterial puncture, or catheter malposition.
•Pain or swelling at the insertion site.
•Pneumothorax: Rare in PICC lines, but can occur if improperly positioned.
Late Complications:
•Thrombosis:
•Incidence higher in hematology patients due to hypercoagulability (e.g., in malignancies).
•Signs: Swelling of arm/neck, catheter dysfunction.
•Infection:
•Catheter-Related Bloodstream Infections (CRBSI):
•Most common pathogens: Coagulase-negative Staphylococcus, Gram-negatives.
•Risk increases with prolonged use or inadequate hygiene.
•Catheter Occlusion:
•Caused by clots, drug precipitates, or fibrin sheath formation.
•Malposition/Migration:
•Tip migration can lead to dysfunction or arrhythmias.
3️⃣ Precautions
•Before Insertion:
•Thrombocytopenia: Ensure platelets >50,000/mm³; transfuse if needed.
•Neutropenia: High infection risk; strict aseptic technique.
•Anticoagulation: For patients on anticoagulants (e.g., due to VTE), assess bleeding risk.
•Allergy: Check for allergies to catheter materials (e.g., latex).
•During Insertion:
•Aseptic Technique: Follow sterile barrier precautions (gown, gloves, drapes).
•Imaging: Use ultrasound guidance for vessel identification.
•Tip Positioning: Confirm placement in the lower third of the SVC or cavoatrial junction via fluoroscopy or post-procedural chest X-ray.
•After Insertion:
•Securement: Use a stabilization device to prevent migration.
•Flush Protocol: Regular flushing with saline/heparin to maintain patency.
•Dressing: Transparent dressings; change weekly or when soiled.
4️⃣ Practical Positioning Tips
•Vessel Selection:
•Basilic vein: Preferred due to larger diameter and straight course.
•Cephalic vein: Secondary choice; smaller and more tortuous.
•Optimal Tip Position:
•Verify at the cavoatrial junction (CAJ) to avoid arrhythmias or venous thrombosis.
•Avoid placement in the right atrium (risk of perforation).
•Arm Positioning During Insertion:
•Supine position with the arm abducted at a 90-degree angle.
5️⃣ Exam-Wise High-Yield Tips
•Indications for PICC: Repeated IV access for chemotherapy, irritants, and vesicants.
•Key Complications: Thrombosis, infection, and catheter malposition.
•Thrombosis Prevention: Use prophylactic anticoagulation in high-risk patients when indicated.
•Infection Prevention: Strict sterile protocols during insertion and dressing changes.
•Tip Confirmation: Ensure CAJ positioning using imaging techniques (X-ray or fluoroscopy).
Mnemonic for PICC Safety: “PICC SAFE”
•P: Position confirmed at CAJ.
•I: Infection control (sterile technique).
•C: Clot prevention (flush protocols).
•C: Chemotherapy compatibility.
•S: Secure the catheter.
•A: Assess thrombosis signs (arm swelling).
•F: Flush routinely.
•E: Educate patients on catheter care.
#HemeOnc #PICCLine #ChemoSafety #Complications
#Myeloma Paper of the Day: Response rate & EFS to 2nd line dara/bortez/dex in relapsed/refractory light chain AL #amyloidosis after initial bortez-based regime are better if prior response was CR/VGPR & if relapsed disease vs. inadequate prior response: https://t.co/Hw7Gx3a6yN.
#Hematology Cardiovascular Management of Patients Undergoing Hematopoietic Stem Cell Transplantation: From Pretransplantation to Survivorship: A Scientific Statement From the @American_Heart Association | @CircAHA #CardioOnc#bmtsm#survonc https://t.co/p0KcOHwiIY
📘Ya tenemos disponible para su descarga la actualización de la "Guía de práctica clínica para el DIAGNÓSTICO, TRATAMIENTO Y SEGUIMIENTO DEL LINFOMA DE HODGKIN 2023". Encuéntrala en la web de GELTAMO. @geltamo@sehh_es@SEHHJoven
💻https://t.co/sHIRrlC2a2
💻 New user accounts 💻
Feature1️⃣️: Personalizing your areas of interest 🔍
Select a trial, congress, or any relevant #multiplemyeloma disease areas to the 'Areas of interest' section; this content will be used to suggest further recommendations.
https://t.co/7Z0XEPqI75
#ASH23